ICICI Pru Nifty Pharma Index Fund-Dir (IDCW) - Mutual Fund Analysis | Complete Fund Review with Performance, Portfolio, and Risk Analysis
Comprehensive analysis of ICICI Pru Nifty Pharma Index Fund-Dir (IDCW) (43469) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
ICICI Pru Nifty Pharma Index Fund-Dir (IDCW)
ICICI Prudential Asset Management Co Ltd
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Fund Health Radar
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Performance
Weak Returns
Risk
High Risk
Expenses
Low Expense Ratio
Portfolio Mix
Equity Focused
Management
Established Team
Quality Score
Average Quality
ICICI Pru Nifty Pharma Index Fund-Dir (IDCW) - NAV History (1Y)
Showing 1Y NAV history
Performance across different time periods
Neutral Entry Point
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Neutral Entry Point
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Key Factors Analysis
Long-term Track Record
Historical performance consistency
Alpha Generation
Outperformance vs benchmark
Equity Exposure
Market exposure level
Cost Efficiency
Fund management costs
1-Year Returns
Recent performance momentum
Management Stability
Fund manager experience
Risk Assessment
Risk-adjusted returns
Fund Size
Assets under management
Investment Timing Insights
3Y Performance Comparison
This fund has outperformed its benchmark by 0.43% over the 3Y period.
See how your money can grow and compare with popular investment options
Your Investment
Compare With Popular Options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
Risk Metrics (3 Years)
Risk Level
| Company | Sector | % Assets |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | 22.49% |
| Cipla Ltd | Pharmaceuticals | 10.69% |
| Divis Laboratories Ltd | Pharmaceuticals | 10.24% |
| Dr Reddys Laboratories Ltd | Pharmaceuticals | 9.45% |
| Lupin Ltd | Pharmaceuticals | 5.70% |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals | 4.78% |
| Laurus Labs Ltd | Pharmaceuticals | 4.18% |
| Glenmark Pharmaceuticals Ltd | Pharmaceuticals | 3.93% |
| Aurobindo Pharma Ltd | Pharmaceuticals | 3.90% |
| Mankind Pharma Ltd | Pharmaceuticals | 3.54% |
Sector Breakdown
Compare against Index Fund category average
Performance Summary
This comparison shows how the fund performs relative to the Index Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Index Fund category
ICICI Pru Nifty Pharma Index Fund-Dir (IDCW) vs Category Average
Similar Funds Comparison
| Fund Name | NAV | 3M | 6M | 1Y |
|---|---|---|---|---|
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (IDCW) | ₹1247.44 | -1.03% | 4.26% | 8.39% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (G) | ₹1247.44 | -1.03% | 4.26% | 8.39% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (G) | ₹1242.74 | -1.07% | 4.18% | 8.23% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (IDCW) | ₹1242.72 | -1.07% | 4.18% | 8.23% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (G) | ₹1220.00 | 1.16% | 4.38% | 8.21% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (IDCW | ₹1220.00 | 1.16% | 4.38% | 8.21% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (IDCW) | ₹1215.39 | 1.13% | 4.31% | 8.05% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (G) | ₹1215.38 | 1.13% | 4.31% | 8.05% |
| HDFC BSE Sensex Index Fund - Direct | ₹792.87 | 0.30% | 11.07% | -1.48% |
| HDFC BSE Sensex Index Fund - Regular | ₹773.82 | 0.26% | 10.99% | -1.63% |
Category Average Returns
Nishit Patel
A seasoned investment professional with over 3 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.